from our files PARKINSON'S DISEASE -
Treatment with
levodopa, alone or in combination
I,..oopa IlId • cubidopal L-oopa wmbislation ('Sincmtt') in the trel.lnJenl of Parkinson's disease: a compantive study. Strcifler, M. et ,I. Pharmatherapeutiao I: 89 (1916) Absence of relationship between L-dopa plasma levels and Iherapeutic effecl in Partin!Dn"s disease Ireated ""1m L-dopa. Algeo. S. eI ll. EuropUn Neurology.4,219(1976) Study of deterioration in Ion,-tenn troItmentofParkinsonis.m with L..dopa pJusdecarbo~yla.o;.e inhibitor. Ludin. H.P. Cl al. Journal of Neural Transmission 38; 249 (976) MOIUlity anIOlI& Partiruon patients ue;otW with L-dopa combined with a decarbo~ylase inhibilQr. Zumstt:in, H. eI at Europan Neurology 14: 121 (1916)
I..evodopa and decarboxylase inhibitions:A rev~w of their cl inical phumacology and use in the treatment of Parkinsoni5m. Pinder. R.M. CI at Drugs I ]: J29(1916) Trulmtnl of Parkiru;on ', syndrome .... it!! L-dopaand dope decarbluybse inh ibitor. Granerus. A.K. et al. Akl\ltlLe ~ronlOlo&ie6: 23 (19761 L-dop,l-carbidop3: Combined therapy for the treatment of Parkinson's diseal;e , Celesia. G,G, et ai, Oiseasesofthc Nervous System)7: 12) (I !J76) Trutment of Parlinsonism: Bromocriptine, carbidopa/levociopa, and Ievoclo9l.comp;uC!l;l in I.double,blind 5Wdy. KartzineJ. R, et ai, NeurolD,y 26: 372 (] 976) SiJ yearsofhigh, levellevo
R04-4602 . Campella, G. et al. European Journ.u ofOinical Pharmacology II : 255(1977) KaJiureticelTect of L-dopa treatment in ParkinSllnian patients. Graneros, A.· K. et aI. Acta Med ici. Seandina~ica 20/ , 291 (l977J LeVOOOpa treaunmt of presenile dementia, Kristensen, V. et al. Aaa Psychiatrica ScandinaviQ, 55: 41 (1917) Levooopa and decarboxylase inhibitors in Parki nSlln·sdisease. Gj[Jand , O. Larkastidrtingen 74: J9 (I 977) Varia\ioJU of \herlIpeutic .,;:tion (on-(lif phtnomcoon) in Park inson paticnu chronically traIN with L·Oopa or I...·do~ plus 100. Carolei. A. tI ill. La Clinica Terapeut1ca SO: lSI (1977) Oclilar dyskinesias in patients with Parkinson', disease treated with levodopa. Shimizu, N. etal. AIINoI!; of NeurolDlY I: 167 ([971) Success and problelJlS of lolli-term levodopa thtnpy in ~rkinson's disease. Mrasden, CD. etll, Laneet I: 345 (1977) Implications of combined treatmenl with madopar and l...-depreniJ in Park inson's disea.-e. Birkmayer, W. et a!. i..MIcet I: 439 (1977) Treatment of Puklrnion syooromc with L·dopa.(oontinuedl. Ribadeau Dumas. J .•\.... till. The~pie 32: 161 (1917) Levodopa in Parkill5Onism, Siome, R. Saulh African Medical Journal 51 : 3)8 (]977) Long·term le~odopa in Parkinson's diHase. Yahr, M.D. Laocet I: 706 (1977) Sustained le~odopa rfflClCy in Parkinsonism. Schneider. E. et II. Ocr Nervenant 48: 205 (1971) JUVe nile P' rk insono.;m traIN with le~OIkIpa. Sachtlev, KK , el a!. Archi~ts of N~urQlolY 34: 244(1977) Episodic failure ofabsoff/tion of levodopa, A (actor in the oonl1o1 of clinical fluctuations in the trQtmmt orPartin$ooism. Fahn, S. /'Ieurolol)' 21, )90fl97J) EfftIC1.'i of N·propylnoraporphine on the lolli-urm trQlmeDt of Parkinoonism with Ievodopa. PapavuiliOll, P.S. et II. Neurolol)' 27, 390 (1 977) Treatment of Parkinson's disease with the combined preparation l.-dop,a/Lcar\)idopll. Hayek, J. Schweizerische Medizinischf: Woc:l\tnschrift 101, 474 (977) Psychiatric problems. Wesl Vir&inia Medial 10umal7l: 10! (1977) The value of the combin.tion bromocriptine,levodopjl in low tlosage in Parkinsonian pa,ticnUl Iooe treated with L-dopa. Peth. H. Nouvelle Presse Medicale 6, 1658 (1971) IntcrKtion between bromocriptinc and levodop;il: Biocbemi<:al basis for an improved treallrlent for Parkinsonism. Hun. CS, et: aI . Nellrolol)' 27: (977) Theophyllamioe and the .ntiparltinsoniln response 10 levodopa trealmenl MlllnU5Sen. l . CI aI . Aaa NeuroloaiQ Seandinavica 56, 29 (1911) Sioernet in the treatment of Parkinson's tliscase. Kon , S.H. l.ahey Oinic Foun~tion Bulletin 26, r 35 (1977) Autoimmune haemolytic anaem ia in I patient with Parkinson's disease treated wjlh thecombination: I...·dopa/carbidopa. 8ar&t. M. et al. La Nouvelle Pres;st Med iale 6: 2442 (1977) Amantadine and a flied eombination oflevodopa and carbidopa in the treatment of Parltinson's d~. Sa~ery, 1. Disease:; of the Nervous System 38: 605 (1977) Combined therapy of Part.insonism with bromocriptioe, L·dopa ,,!d decarboxylase inhibi tor. Vardy, Y. et aI. Harduah 93: 129119JJ) Antaaonism by piperidine oflevotlopa effects in Parkinson 's d~ Tolo5lo, E,S. ct ll. Neu rolDlY 27: 875 (1 977) Bromocriptinc alone or associated with l.-dopa pillS benseruide in Parkinson's disease. ~racenj, T,A. et: aI. Joumill of Neurology, NeurosufleIY and Psycbiatry 40: 1142 (1977) Effe.:t of ltvodopa on 'fronllr signs in Parkinsonism. Morel·Maroser, A, British Med ical Journal 2, I S4) (1977) Myoclonic atllclts indU
5o,
INPHARMA 9th S.plember. 1918 p19
Unwo::eS$fu)lreallnenl with kvodopa orl Parkinsonian p,a.tXnt with calcifICation of tile basal ganglia, Berende:s, K. et al. Journal of NcurololY ZeiCSChrirt (uer Neuroloaie 218: S I (1918) Efficacy Ind safety orcafbidopaJlevodopa in the treatment of Parkinson 's disease. ~ro. S.E. hnestigacion Medica In!t:macional 5: 64 (1978) factof"S innuel"lCing \he OIXIImnetor"on-oli symptoms during Iolljjterrn treatment with L-depa. Graneros, A.K. Acta Medica Se.ndinarica 20), 7S(1978) Bromocryptine in k"oOOJ>a Te.!.pQns.c-losillJ Parkinsonism. Jansen, E.N.H. European Neurolog)' 17: 92 (1978) UnuSllal ~ymptoms in Parkinson's disease; positiveerrect.~ of L-dopa. M o~l Maroi;et, A. Ci aI . Tllerapie )3: 129 (1978) I..evodopa in Pukinson disease: A Iona,!t:rm appraisal ofmortality.10$Cph. C. eta!. AnlDls ofNeuroio&Y J: 116 (I 978) Four'year trea~ni orpatXnlS with Parkinsonism usin. Im3.lltadine IJone or with Itvoc!op,i.. Timberlake. W .H. etll. Annals ofNeuroloiY 3: 119 (1978) Lolli-term uu.unent of Parkinson's disease with L-dopa atld dopa.decarboly1ase inhibitor: Therapeutic rC$ults and side effecL Battistin. L et aI. Acta Neurologica Sc:andina~ica H : ] 86 (1978) A double -blind comparil\On oflevQdopa. mldop
Aoalysis of the cJ:inic.al problems in Pukinsonism and of the GOmplic.loollS of lona-term levodopa therapy. I...esser, R.P. etal. NeurolOiY 28, 342 (\978)
